The First Protocol With Health Regenerative Solutions
LyfeCel doesn't just fund medical research, we bridge Web3 funding and longevity medicine to deliver real regenerative treatments for our backers.
A Global Crisis in Regenerative Therapies
The science is ready. The funding model is broken. Millions suffer while breakthrough treatments remain inaccessible due to outdated financial systems.
Access Denied
- Treatments classified as "elective" or "experimental"
- Insurance won't touch them—claims automatically rejected
- Patients forced to pay $20,000+ out of pocket or suffer in silence
Capital Locked
- Opening a high-grade stem cell lab costs millions in upfront capex
- Traditional VC is too slow (5-7 year horizons)
- Government grants are too restrictive and bureaucratic
Time Running Out
- Patients with degenerative conditions can't wait 10+ years for FDA approval
- Aging population needs solutions now, not decades from now
- Proven treatments available abroad remain inaccessible domestically
What is LyfeCel?
The first decentralized protocol that doesn't just fund medical research, we physically treat stakers & backers. We've built a complete ecosystem connecting Web3 capital with real-world regenerative medicine.
Real Treatment Centres
Protocol-funded stem cell and regenerative medicine centres that physically treat individuals. Not just research—actual health solutions delivered today.
Demand-Backed Token
$LYFC is backed by real healthcare demand. Every treatment generates protocol revenue, creating sustainable tokenomics tied to actual healthcare services.
Longevity Medicine
Access cutting-edge regenerative treatments: stem cell therapy, exosome treatments, NAD+ infusions, peptide protocols, and emerging longevity interventions.
How the Protocol Works
Token Holders Fund Centres
$LYFC holders stake tokens to fund the development and operation of regenerative medicine centres
Centres Treat Patients
High-grade stem cell labs and treatment centers deliver real regenerative therapies to patients
Revenue Flows Back
Treatment fees generate protocol revenue that's distributed to stakers and treasury
Expand & Scale
Treasury funds new centres, research, and patient subsidies—creating a virtuous growth cycle
$LYFC Tokenomics
The first healthcare token backed by real stakers demand. $LYFC powers the entire LyfeCel ecosystem, enabling centre funding, governance, and sustainable yield from actual medical services.
Sale Configuration
1,000,000,000 LYFC
Immediate liquidity, no lockup period.
800,000,000 LYFC
12-month strategic lockup with vesting.
Token Utility
Stake for Yield
Earn real yield from centre revenue & token value
Governance
Vote on protocol decisions
Discounts
Up to 30% off treatments
Priority Access
Early access to new centres
Token Distribution
Strategic allocation ensuring long-term sustainability and ecosystem growth.
Project Roadmap
From token launch to global centre network—follow our journey as we build the infrastructure for decentralized regenerative medicine.
Token Launch & First Centre
- $LYFC Token deployment on TRON Chain
- Initial DEX offering (IDO) completed
- First Centre in KL, Malaysia
- Security audit by CertiK
Centre Network Expansion
- 3 additional SEA centre locations
- Patient portal and booking system launch
- Staking rewards distribution begins
- Treatment outcome tracking on-chain
International Expansion
- Clinic partnerships in Africa & China
- Exosome and NAD+ treatment offerings
- Patient subsidy program launch
- Research partnership announcements
Full Protocol Launch
- 15+ centre network operational
- DAO governance fully activated
- Clinical trial partnerships
- Insurance integration pilots
Meet the Team
A unique blend of healthcare operators, blockchain engineers, and longevity researchers united by a mission to democratize regenerative medicine.
Clarance Teo
CEO & Founder, HF30+ years in complimentary medicine. Expert in Dr.Kelley's protocol, Ozone Therapy Graduate, and Functional Medicine University.
Alex Summers
CTO & FounderEx-Solana Foundation. Built DeFi protocols with $50B+ TVL. Stanford CS. Pioneer in real-world asset tokenization.
Teng GuiFang
Co-Founder, HFSpecialist in Kelley’s protocol. Certified in Healthcare Management, China.
Greg King
CSO & Co-Founder, HF40+ years in healthcare consulting and investor relations. Led multiple early-stage health tech ventures to IPO.
Partners & Backers
Backed by leading healthcare institutions, longevity investors, and Web3 innovators committed to transforming regenerative medicine access.
Healthcare Partners
Investors & Backers
Featured In
Our Community
Join thousands of patients, investors, and longevity enthusiasts building the future of accessible regenerative medicine.
Patient & Investor Stories
"After years of chronic pain and being told nothing could help, LyfeCel's stem cell treatment gave me my life back. Insurance denied me—but this protocol made it affordable."
"Finally, a DeFi protocol with real-world utility. The yield comes from actual centre revenue—not emissions. This is what crypto should be."
"As a longevity researcher, I've waited years for a model like this. LyfeCel is bridging the gap between cutting-edge science and patient access."
Ready to Join the Healthcare Revolution?
Be part of the first protocol that physically treats patients. Fund centres, earn real yield, or access life-changing treatments.